Advaxis, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (31)

View All

Latest Posts

About This Stock More About This Stock
Biotech Stock Advaxis: Outperformer In The Making
Article By: Taki Tsaklanos
Thursday, October 6, 2016 4:00 AM EDT
One of the very promising biotech companies which we covered in May of this year is Advaxis. It is a small cap with a $467M market cap with a potential solution to weaken cancer.
In this article: ADXS
Read
3 Health Stocks To Watch As Health Sector About To Break Out
Article By: Taki Tsaklanos
Wednesday, May 25, 2016 10:00 PM EDT
The health sector was by far the most constructive segment up until last summer. However, it strongly broke down in August, and had a hard time recovering. We have selected 3 stocks in the health sector which deserve the attention of investors.
In this article: HZNP, XLV, ADXS
Read
Aduro Biotech Fails Phase 2 Pancreatic Cancer; Shares Fall 16%
Article By: Terry Chrisomalis
Monday, May 16, 2016 7:16 PM EDT
Phase 2b study fails to echo phase 2a results; survival improvement is statistically insignificant. Could this also be bad news for Advaxis?
In this article: ADRO, ADXS Also: BMY
Read
Money Monday With Strong Trades
Article By: Warrior Trading
Monday, March 21, 2016 4:38 PM EDT
I noted that KTOV had an especially interesting setup being a recent IPO and just below all time highs.
In this article: RMTI, ADXS, KTOV
Read
Advaxis Announces That Its HPV Program Has Been Placed On FDA Clinical Hold
Article By: Terry Chrisomalis
Tuesday, October 6, 2015 7:37 PM EDT
Shares of Advaxis are down 27% in after-hours trade after the company announced that the FDA has placed its HPV program on clinical hold due to one patient death.
In this article: ADXS
Read
All Posts

Latest Tweets for $ADXS

No tweets yet!

PARTNER HEADLINES